A simple, flexible, nonfluorescent system for the automated screening of neurite outgrowth

Journal of Biomolecular Screening

Volumn 11, Issue 2, 2006, Pages 155-164

  Price, Raymond D ^a   Tomoya, O E ^a   Yamaji, Takayuki ^a   Matsuoka, Nobuya ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Image analysis; Nerve growth factor; Neurotrophins; Rho kinase inhibitor; SH SY5Y neuroblastoma

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DYE; NERVE GROWTH FACTOR; RETINOIC ACID; RHO KINASE INHIBITOR;

ANALYTIC METHOD; ARTICLE; AUTOANALYSIS; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; NERVE FIBER GROWTH; NEURITE; PRIORITY JOURNAL; SCREENING;

APHIDICOLIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL COUNT; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CLONE CELLS; DRUG SYNERGISM; HUMANS; NERVE GROWTH FACTOR; NEURITES; RHO GTP-BINDING PROTEINS; TRETINOIN;

EID: 33644956357     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057105283344     Document Type: Article

References (23)

1. Thoenen H, Sendtner M: Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci 2002;5:1046-1050.
2. Pollack SJ, Harper SJ: Small molecule Trk receptor agonists and other neurotrophic factor mimetics. Curr Drug Targets CNS Neurol Disord 2002;1:59-80.
3. Gallo G, Letourneau PC: Regulation of growth cone actin filaments by guidance cues. J Neurobiol 2004;58:92-102.
4. Davies AM: Neurotrophins: neurotrophic modulation of neurite growth. Curr Biol 2000;10:R198-200.
5. Simpson PB, Bacha JI, Palfreyman EL, Woollacott AJ, McKernan RM, Kerby J: Retinoic acid evoked-differentiation of neuroblastoma cells predominates over growth factor stimulation: an automated image capture and quantitation approach to neuritogenesis. Anal Biochem 2001;298:163-169.
6. Ramm P, Alexandrov Y, Cholewinski A, Cybuch Y, Nadon R, Soltys BJ: Automated screening of neurite outgrowth. J Biomol Screen 2003;8:7-18.
7. Smit M, Leng J, Klemke RL: Assay for neurite outgrowth quantification. Biotechniques 2003;35:254-256.
8. Price RD, Yamaji T, Matsuoka N: FK506 potentiates NGF-induced neurite outgrowth via the Ras/Raf/MAP kinase pathway. Br J Pharmacol 2003;140:825-829.
9. Oe T, Sasayama T, Nagashima T, et al: Differences in gene expression profile among SH-SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor. J Neurochem 2005;94:1264-1276.
10. Poluha W, Poluha DK, Ross AH: TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. Oncogene 1995;10:185-189.
11. Jensen LM: Phenotypic differentiation of aphidicolin-selected human neuroblastoma cultures after long-term exposure to nerve growth factor. Dev Biol 1987;120:56-64.
12. Haque N, Tanaka T, Iqbal K, Grundke-Iqbal I: Regulation of expression, phosphorylation and biological activity of tau during differentiation in SY5Y cells. Brain Res 1999;838:69-77.
13. LoPresti P, Poluha W, Poluha D, Drinkwater E, Ross A: Neuronal differentiation triggered by blocking cell proliferation. Cell Growth Differ 1992;3: 627-635.
14. Nakajima M, Hayashi K, Katayama K, Amano Y, Egi Y, Uehata M, et al: Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions. Eur J Pharmacol 2003;459:113-120.
15. Eggert A, Ikegaki N, Liu XG, Chou TT, Brodeur GM: TrkA signal transduction pathways in neuroblastoma. Med Pediatr Oncol 2001;36:108-110.
16. Ivankovic-Dikic I, Gronroos E, Blaukat A, Barth BU, Dikic I: Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins. Nat Cell Biol 2000;2:574-581.
17. Hynds D, Takehana A, Inokuchi J, Snow D: L- and D-threo-1-phenyl-2- decanoylamino-3-morpholino-1-propanol (PDMP) inhibit neurite outgrowth from SH-SY5Y cells. Neuroscience 2002;114:731.
18. Whitley E, Ball J: Statistics review 4: sample size calculations. Crit Care 2002;6:335-341.
19. Milne S, Voss O, McCulloch J, Sharkey J: Stimulus dependent neuronal differentiation in vitro. Program No. 594.20. 2005 Abstract Viewer/Itinerary Planner [Online]. Washington, DC: Society for Neuroscience, 2005.
20. Mueller BK, Mack H, Teusch N: Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 2005;4:387-398.
21. Encinas M, Iglesias M, Llecha N, Comella JX: Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J Neurochem 1999;73:1409-1421.
22. Ramm P: Imaging systems in assay screening. Drug Discov Today 1999;4:401-410.
23. Davis GF, Downs TR, Farmer JA, et al: Comparison of high throughput screening technologies for luminescence cell-based reporter screens. J Biomol Screen 2002;7:67-77.